Introduction
Since its initial identi®cation as a proto-oncogene in the early 1980's, alterations in c-myc expression have been demonstrated in many types of cancer, including Burkitt's lymphoma, myeloid and plasma cell leukemia, breast carcinoma, cervical carcinoma, small cell lung carcinoma, colon carcinoma, osteosarcoma, and glioblastoma (Cole, 1986; Spencer and Groudine, 1991; DePinho et al., 1991) . Deregulated Myc aects cell cycle progression by shortening G 1 while Myc-null ®broblasts exhibit signi®cant G 1 and G 2 lengthening (Karn et al., 1989; Mateyak et al., 1997) . Furthermore, c-myc expression is downregulated following induction of dierentiation and ectopic expression of Myc prevents dierentiation of many cells in vitro (reviewed in Lemaitre et al., 1996) . Myc is capable of transforming cells in vitro and established cells expressing activated c-myc form tumors in animals (Keath et al., 1984) . Transgenic animal models have demonstrated convincingly that deregulated expression of Myc induces tumorigenesis (reviewed in Facchini and Penn, 1998; Henriksson and Luscher, 1996) . However, the mechanism by which Myc causes transformation remains unknown. Although it has been shown that Myc transactivates promoters of several growth promoting genes, more recent evidence suggests that gene repression plays a vital role in Mycmediated cellular transformation.
Current model of Myc function
Myc is a nuclear phosphoprotein and has many hallmarks of a transcription factor. A model of Myc function is summarized in Figure 1 . Myc does not homodimerize in vivo, but can form heterodimers with its protein partner, Max. This heterodimerization is required for sequence-speci®c DNA binding as well as for biological activity (Amati et al., 1993a,b) . Using in vitro oligonucleotide binding assays, it has been shown that a Myc/Max heterodimer is capable of recognizing the core sequence CA(C/T)GTG, termed E-box Myc Sequence (EMS) (Blackwell et al., 1993; Blackwood and Eisenman, 1991; Prendergast et al., 1991; Solomon et al., 1993) . Myc is capable of transactivating an arti®cial construct containing concatamerized EMS sequences in transient reporter assays, although transactivation of this construct is only 3 ± 10-fold over basal levels (Kretzner et al., 1992; Grandori and Eisenman, 1997) . Several growth-associated genes containing EMS in their promoters have been identi®ed as putative targets for transcriptional activation by Myc, including ornithine decarboxylase (ODC), a-prothymosin, cad and others (reviewed in Henriksson and Luscher, 1996; Grandori and Eisenman, 1997) . Taken together, these observations suggest that Myc acts by the direct activation of growthpromoting genes. Sequence-speci®c DNA binding by Myc may be directed by C-terminal binding proteins in addition to Max, such as Miz-1 . Myc/Max binding to EMS-containing promoters may be regulated by Mad network proteins competing for Max binding. Mad/Max complexes directly repress these same promoters. Mad family members associate with Sin3 proteins, which act as scaolding proteins and recruit histone deacetylase to this complex. Together, these proteins repress gene transcription (reviewed in Schreiber-Agus and DePinho, 1998). Transactivation of target gene promoters by Myc may be further regulated by binding of factors to the amino-terminal transactivation domain (see review by Cole and McMahon in this issue).
Cellular transformation by Myc
Myc is capable of transforming several types of primary and established cell lines in culture, including chick embryo ®broblasts (CEF), rodent embryo ®broblasts (REF), the mouse embryonic cell line C3H10T1/2, and Rat1a cells (Heaney et al., 1986; Crouch et al., 1996; Taparowsky et al., 1987; Stone et al., 1987; Small et al., 1987) . Myc requires expression of a second oncogene, such as activated ras for the transformation of most cell types, including REFs (Land et al., 1983; Ruley, 1990) . In contrast, Myc alone is capable of transforming immortalized Rat1a ®broblasts (Small et al., 1987) . Transformation is scored either by focus formation or by growth of colonies in soft agar; the latter measures anchorage-independent growth as well as loss of contact inhibition. Although both assays are used to demonstrate cellular transformation, each often exhibits varying results in the analysis of point or deletion mutated Myc proteins (Stone et al., 1987; Henriksson et al., 1993; Pulverer et al., 1994) , raising the possibility that they measure dierent aspects of Myc function.
Structure/function analysis of Myc reveals that several highly conserved domains of Myc protein are necessary for its transforming activity in cells ( Figure  2 ). These regions include the highly conserved Nterminal Myc Boxes I and II (MBI and MBII), as well as the basic region, helix ± loop ± helix, and leucine zipper motifs in the carboxy terminus (Stone et al., 1987; Sarid et al., 1987) . Carboxy terminal structures are necessary for DNA binding as well as proteinprotein interactions including dimerization with Max. The N-terminus acts as a transactivation domain which contains multiple phosphorylation sites, mainly clustered within the ®rst 100 amino acids Hann, 1994, 1997; reviewed in Henriksson and Luscher, 1996) . Mutations aecting phosphorylation occur in v-myc as well as in c-myc alleles found in several tumor cell lines; the most prevalent mutation occurs at or near threonine 58, resulting in a loss of phosphorylation at this site (Hoang et al., 1995) . Mutations of myc aecting phosphorylation often result in a protein which has a higher transforming potential (Henriksson et al., 1993; Hoang et al., 1995) .
Protein ± protein interactions may modulate Myc's transforming ability. One interacting protein, BIN-1 (for Box-dependent myc-INteracting protein-1 or Bridging INtegrator-1), was identi®ed through interaction with the MBI region of Myc, but requires both the MBI and MBII regions for association with full-length Myc. BIN-1 binding inhibits Myc-mediated transformation (Sakamuro et al., 1996) . In contrast, a factor which requires MBII for interaction, designated TRRAP (for TRansformation/tRanscription domainAssociated Protein), seems to be required for Myc- (Brough et al., 1995; McMahon et al., 1998) . This requirement is supported by the fact that the TRRAP-binding region of Myc is necessary for transformation. A role for TRRAP in Myc-mediated transformation is further supported by ®ndings that presumptive dominant-negative TRRAP genes or antisense TRRAP RNA blocks transformation by Myc (Brough et al., 1995; McMahon et al., 1998) .
Several proposed Myc-activated genes have been directly linked to immortalization and transformation of cells in culture. One example is ODC, which can transform NIH3T3 cells when overexpressed (Auvinen et al., 1992; Moshier et al., 1993) . Antisense experiments further suggest that ODC is required for transformation by v-src (Auvinen et al., 1992) . More recently Myc has been shown to upregulate telomerase activity by transcriptional activation of the catalytic subunit of telomerase, hEST2/TERT (Wang et al., 1998; Greenberg et al., 1999) . Telomerase activity is associated with cellular immortalization and may also play a role in tumorigenesis (reviewed in Counter et al., 1992; Kim et al., 1994; Zakian, 1997) . However, telomerase activity alone may not be sucient for immortalization in all cell types. Overexpression of either Myc or hEST2 in normal human mammary epithelial cells (HMEC) extends the life span of these cells in culture. However, normal human lung ®broblasts (IMR-90) acquire an extended life span only when Myc was overexpressed. The overexpression of hEST2 and subsequent increase in telomerase activity in these cells was not sucient to overcome senescence in culture. Therefore, Myc seems to activate a pathway alternative to telomerase activity which is required to extend the life span of some cells in culture (Wang et al., 1998) .
The link between Myc gene regulation and transformation has been explored using various altered forms of Myc, and studies have demonstrated that Myc/Max heterodimerization is critical for transactivation, transrepression, and transformation (Amati et al., 1993a; Desbarats et al., 1996; Facchini et al., 1997; Soucek et al., 1998) . For example, MycEG and MaxEG, c-Myc and Max proteins with modi®ed leucine zipper domains that can heterodimerize with each other but not with endogenous proteins, must be expressed together to transform cells and to transactivate gene expression from a Myc/Max DNA binding site (Amati et al., 1993a) . MycEG and MaxEG have been utilized to demonstrate that Myc/Max heterodimerization is necessary for autorepression , although the extent of this requirement in repression of other Myc target genes is not yet known.
Gene repression
Several genes have been identi®ed recently as targets for transcriptional repression by Myc, and it is not surprising that many of these genes have roles in cell cycle or growth regulation (Table 1) . Several examples of Myc-repressed genes and potential mechanisms of Myc repression are discussed in detail below.
Feedback regulation
On one level, Myc-mediated repression serves as a feedback mechanism to regulate its own expression. Feedback repression, or autorepression, is observed in Myc-transformed cells as well as in transgenic mice (Keath et al., 1984; Adams et al., 1985; Lombardi et al., 1987) . This repression occurs at the level of transcriptional initiation, but while dependent on Myc/Max activity other factors are likely to be required (Cleveland et al., 1988; Penn et al., 1990; Grignani et al., 1990; Facchini et al., 1997) .
Myc also represses transcriptional activation of platelet derived growth factor b receptor (PDGFbR) by a mechanism distinct from that of autorepression. Since Myc expression is upregulated following PDGFbR activation (Blanchard et al., 1985) , PDGFbR repression may actually represent another form of Myc self regulation. This dierence in mechanism of repression is shown by fusion of a variant mouse NIH3T3 cell line, which is de®cient for Myc-mediated pdgfbr repression and autorepression, to 
Cell adhesion genes
The repression of cell adhesion genes by Myc may contribute to the transforming ability of Myc. The lymphocyte function-associated antigen-1 (LFA-1; aLb2 integrin) plays a role in cell-cell contacts necessary for immunological responses (reviewed in Springer et al., 1987) . Enforced expression of c-Myc in human B lymphoblastoid cells immortalized with Epstein-Barr virus leads to a downregulation of LFA-1 expression and reduction of aL transcription . This reduction of LFA-1 expression is associated with a decrease in homotypic cell adhesion and adherence to resting or activated, endothelial cells Paganin et al., 1994) . Overexpression of Myc has also been associated with the reduced expression of a3b1 integrin in a small cell lung carcinoma cell line, NCI H209. a3b1 protein levels are diminished due to a reduction in a3 transcript levels, although it is not clear if Myc overexpression is aecting transcriptional activation or RNA stability (Barr et al., 1998) . Myc-induced anchorage-independent growth of these cells and increases growth rate. Restoration of a3 expression in Myc-overexpressing cells decreases soft agar growth, although growth rates remain elevated (Barr et al., 1996 (Barr et al., , 1998 . This result suggests that downregulation of adhesion molecules by Myc can contribute to the loss of contact inhibition which is characteristic of cellular transformation.
Dierentiation-speci®c genes
Enforced expression of Myc inhibits dierentiation of a number of cell types, while blocking c-myc expression or activity can induce dierentiation in culture (reviewed in Spencer and Groudine, 1991; Facchini and Penn, 1998) . Myc represses the expression of several dierentiation-associated genes, including the C/EBP regulated genes mim-1 and lysozyme as well as C/EBPa itself (Mink et al., 1996; Li et al., 1994) . Myc represses the promoter of C/EBPa, and cells expressing v-myc exhibit decreased RNA levels of C/EBPa and b (Li et al., 1994; Mink et al., 1996) . However, Myc represses transcriptional activation of the mim-1 promoter even when C/EBPa or b are constitutively expressed (Mink et al., 1996) , suggesting that Myc represses this promoter independent of C/EBP protein downregulation. In fact, Myc has been found to bind and regulate C/EBP enhancer sequences . By preventing dierentiation and/or cell cycle arrest, deregulated Myc forces cells to remain in a proliferative state, which can predispose a cell to transformation.
Cell cycle/growth-arrest genes
Repression of cell cycle inhibitory genes provides an alternative means to promote cell growth. The Growth Arrest and DNA Damage (GADD) genes were originally identi®ed as transcripts induced by DNA damaging agents, and are subsequently found to be upregulated upon cell cycle arrest by a variety of agents (reviewed in Sanchez and Elledge, 1995) . Myc has been shown to repress gadd34, gadd45 and gadd153 expression (Chen et al., 1996; Amundson et al., 1998) . The best characterized of these genes is gadd45, which is upregulated at the transcriptional level in a p53-dependent or -independent manner, and can induce cell cycle arrest when overexpressed (Kastan et al., 1992; Zhan et al., 1994a,b; Smith et al., 1994) . Repression of gadd45 transcription by Myc is rapid, and is mediated through a region proximal to the start site of transcription Amundson et al., 1998) .
The Growth Arrest Speci®c (GAS) genes are a group of genes that are downregulated following growth induction of arrested NIH3T3 cells (Schneider et al., 1988) . Conversely, Myc expression is induced upon serum stimulation and it has been demonstrated that Myc represses transcription of gas1 . Finally, Myc has been shown to repress transcription of the cyclin-dependent kinase inhibitor p27 KIP1 , which induces cell cycle block by binding cyclin/cdk complexes and inhibiting their activity (reviewed in Sherr, 1994; Morgan, 1995; Sherr and Roberts, 1995 KIP1 by a combination of these mechanisms. Collectively, these data suggest that Myc functions on several levels, including transcriptional repression, to promote growth and prevent cell cycle arrest.
Potential mechanisms of repression
The mechanism of Myc-mediated gene repression is still unclear. It has been shown that Myc is capable of binding and repressing transcription via Inr elements (Roy et al., 1993b; Li et al., 1994; Mai and Martensson, 1995; Lee et al., 1996; Peukert et al., 1997 ; W Yang, MJ FitzGerald, M Wu, RE Bellas, DW Kim, J Shen, Z Suldan, LP Freedman and GE Sonenshein, manuscript submitted). The Inr element is generally accepted to have the weak consensus sequence YYCAYYYYY, where Y is a pyrimidine base (Corden et al., 1980; Smale and Baltimore, 1989) . TFII-I has been shown to bind and stimulate basal transcription from the Inr element (Roy et al., 1991) . Binding of TFII-I to Inr elements is followed by sequential addition of other general factors, providing a mechanism for initiation of transcription from TATA-less promoters (Roy et al., 1993a) . It has been demonstrated that Myc can bind TFII-I and form a complex associated with DNA containing an Inr sequence. This complex resists further binding of basal transcriptional machinery, and thus prevents transcriptional activation from the Inr (Roy et al., 1993b (Roy et al., 1993b) . Also, binding of Myc/ Max complexes to the Inr element in the p27 promoter has recently been demonstrated by EMSA. Other evidence of direct gene repression by Myc comes from experiments utilizing the inducible Myc-estrogen receptor (MycER) system (Littlewood et al., 1995) . The MycER fusion construct consists of Myc protein fused to a modi®ed regulatory domain of the estrogen receptor, which renders the protein inactive unless it is activated by the addition of an estrogen analog, hydroxytamoxifen (OHT). It has been shown that downregulation of gadd45 or gas1 RNA occurs within 3 ± 4 h after activation of the Myc fusion protein. Such rapid repression at the RNA level suggests direct regulation; however, indirect regulation has not been ruled out .
Additional evidence supporting a role for Myc-mediated repression
Several lines of evidence point to the biological relevance of Myc-mediated gene repression. The development of Myc null cell lines has provided a needed tool for the examination of Myc function. Homologous recombination knock-out of c-myc in Rat1 ®broblasts resulted in a signi®cant decrease in growth rate and lengthened G1 and G2 phases compared to parental cells (Mateyak et al., 1997) . Recently, these cells have been analysed for expression dierences in some putative Myc-regulated genes, including c-myc, cdc25A, ODC, a-prothymosin, MrDb, cad, eIF4E, LDH-A, RCC1, p53, ECA39 and gadd45. When RNA levels were compared between parental, Myc-null, and Myc-replaced null cells, it was found that only c-myc, cad and gadd45 gene expression was dependent on Myc (Bush et al., 1998) . Therefore, many of the putative Myc-activated genes do not seem to be dependent on Myc for their expression, and so probably do not contribute to the growth defects of the Myc null cells. However, a role for gene repression is suggested by the changes in gadd45 and c-myc expression.
Analysis of a Burkitt lymphoma-derived Myc protein demonstrates a link between Myc-mediated repression and transformation. This mutant protein, designated MycB2, contains a point mutation within the region shown to be important for Myc repression of transcription. Although MycB2 transactivates similarly to wild type Myc, it represses the adenovirus major late promoter (AdMLP) more strongly than wild type. When analysed for transformation ability, MycB2 has more potent transforming ability compared with wild type Myc (Lee et al., 1996) . Furthermore, analysis of a second Burkitt's lymphoma mutant, designated MycW136E, was found to have increased transactivation ability, but decreased repression and reduced transforming ability (Lee and Dang, 1997) . These results suggest that Myc-mediated repression, rather than transactivation, correlates with transformation.
Additional studies also suggest that the transactivation and transformation functions of Myc do not correlate. A mutated Myc lacking MBII (aa 106 ± 143) is defective for transformation yet retains the ability to transactivate through Myc/Max DNA binding sequences, although an exception to this rule may be the a-prothymosin promoter (Li et al., 1994; Gaubatz et al., 1994) . However, it has been demonstrated that this protein has lost repression function (Li et al., 1994; Mahrin et al., 1997) . Our lab identi®ed a naturallyoccurring truncated form of the Myc protein, termed MycS, which arises from alternative translational initiation. This protein lacks the ®rst 100 amino acids of the transactivation domain, including MBI, but retains MBII (Spotts et al., 1997) . Although this protein is incapable of transactivation of arti®cial and natural promoters, it retains the ability to repress promoters such as gadd45, gas1 and AdMLP. Furthermore, MycS can stimulate proliferation, transform Rat1a ®broblasts, induce apoptosis in low serum conditions, and rescues the slow growth phenotype in Myc null ®broblasts (Xiao et al., 1998) . Therefore, direct transactivation of genes does not seem to be required for many Myc-mediated cellular processes and gene repression may be sucient for many aspects of Myc function.
Comparison and contrast of E1A with Myc
Parallels between Myc and E1A have often been drawn. E1A, like Myc, promotes cell growth, transforms cells, inhibits dierentiation, and induces apoptosis (Zantema and van der Eb, 1995; Nevins, 1995; White, 1995; Jones, 1995; Brockmann and Esche, 1995) . Like Myc, E1A has two highly conserved boxes, CR1 and CR2, which are required for transformation as well as gene regulation (Zantema and van der Eb, 1995; Jones, 1995) . These regions facilitate proteinprotein interactions which mediate E1A functions. Two major proteins bind to these regions of E1A, Rb and p300. Rb prevents cell cycle progression by sequestering the E2F transcription factor and preventing the transactivation of E2F regulated genes. E1A binds Rb through the CR1 and CR2 regions. It has been proposed that E1A prevents Rb binding to E2F by ®rst associating with Rb through the CR2 domain of E1A at a site on RB distinct from E2F binding. The CR1 region then competes for E2F binding. Once E2F is liberated, the CR1 interaction blocks subsequent binding of E2F to Rb (Nevins, 1995) . The other major protein bound by E1A is the p300 coactivator. E1A binds p300 through the CR1 region and prevents p300 activity, thereby repressing general transcription. The region of CR1 which binds p300 does not overlap with the portion of CR1 which is involved in Rb binding (Nevins, 1995; Brockmann and Esche, 1995) .
Striking similarities between E1A and Myc suggest that these proteins function through the same pathways and share similar protein interactions, although the speci®c mechanisms may be distinct. MBI and II may interact with proteins necessary for Myc function in a manner similar to E1A interactions described above. It has been demonstrated that E1A and Myc bind TBP through similar epitopes (Hateboer et al., 1993) and the same region of TRRAP which is necessary for transformation by Myc is also necessary for E1A-mediated transformation (Brough et al., 1995) . Furthermore, Myc/E1A chimeras analysed for REF cotransformation with ras reveal that transforming regions of Myc and E1A complement each other, with Myc complementing the role of CR1 (Ralston, 1991) . These regions have been suggested to have similar structures (Figge et al., 1988; Ralston and Bishop, 1983) , although this is not con®rmed, so it is possible they may have similar protein-protein interactions.
Another similarity to c-Myc is that there are two forms of E1A proteins, consisting of 243 amino acids (short form) and 289 amino acids (long form). Unlike Myc proteins, which arise from alternative translation initiation, E1A proteins are translated from separate transcripts which arise as a result of dierential splicing. The short form lacks a conserved region located in the central part of the protein, CR3, which is necessary for direct transactivation of viral proteins. The lack of transactivation function of the short form is similar to MycS. However, the short form carries out the same cellular functions as the long form. Both protein forms are capable of transcriptional activation as well as repression, although both of these activities seem to be independent of direct binding of DNA by E1A (Shenk and Flint, 1991; Zantema and van der Eb, 1995) . Myc diers from E1A in this respect, since direct binding of DNA by Myc complexes have been demonstrated. However, although some evidence exists, there is no proof that direct DNA binding is required for Myc-mediated repression. The parallels between Myc and E1A may be applied to explain the apparent contradiction that Myc is capable of both transactivation and repression of genes. N-terminus with other factors bound with high anity to other elements in the same promoter. By analogy to E1A, Myc-mediated repression might prove to be less dependent upon sequence-speci®c DNA binding, but more directed by protein±protein interactions with other DNA-associated factors. In either of these scenarios, the expression of genes such as gadd45, C/EBPa, or integrins would be repressed. This repression promotes cell cycle progression and prevents dierentiation, and can lead to transformation.
Summary and alternative model for Myc function
The idea that Myc-mediated repression is sucient for function raises the question: what is the role of Myc-mediated transcriptional activation? Transactivation of genes may have a role in very speci®c facets of Myc activity. Perhaps gene activation by full length Myc is important in terms of cellular immortalization. Full length Myc dimerized with Max activates transcription of genes, such as TERT/hEST2, which are associated with immortalization of cells. Through experiments utilizing MycS, we have demonstrated that transactivation of genes is not necessary for ful®lling several Myc-mediated activities. However, these experiments were performed in an immortalized cell line. Indeed, MycS does not appear to cooperate with ras in the REF focus formation assay. The lack of MycS activity in this assay may re¯ect a dierence in immortalization, as opposed to transformation, function. This dierence may lie in the activation of genes which are required to render REF cells susceptible to transformation by ras, since ras alone has been shown to induce senescence (Serrano et al., 1997) . Interestingly, TRRAP binding is necessary for Myc/ras cotransformation, and it is unlikely that TRRAP binds to MycS, since it will not bind a D1±110 amino acid deletion of the N-terminus of Myc (McMahon et al., 1998) . On the other hand, TRRAP antisense does not aect Myc-mediated apoptosis or cell cycle progression, which can be induced by MycS (M Cole, personal communication) . This data again suggests that the Myc/ras cotransformation assay measures a distinct function of Myc. One caveat to these interpretations is that the Myc/ras cotransformation assay may be more sensitive to levels of proteins than the other assays. For example, MycS may not be translated eciently in REF cells, or threshold levels may dier in the REF versus Rat1a assays when TRRAP is reduced by antisense. In contrast to the requirement of TRRAP protein for Myc/ras cotransformation, MBI binding proteins, such as BIN-1, may act as general inhibitors of Myc activity. MycS escapes this regulation since it lacks MBI. These observations further suggest that Myc functions through several independent pathways. Thus, while gene transactivation may have a role in some cellular functions, the transcriptional repression of genes is sucient for most Myc-mediated biological activities.
